Methylation of the DFNA5 increases risk of lymph node metastasis in human breast cancer

Biochemical and Biophysical Research Communications

Volumn 370, Issue 1, 2008, Pages 38-43

  Kim, Myoung Sook ^a   Lebron, Cinthia ^a   Nagpal, Jatin K ^a   Chae, Young Kwang ^a   Chang, Xiaofei ^a   Huang, Yiping ^a   Chuang, Tony ^a   Yamashita, Keishi ^a   Trink, Barry ^a   Ratovitski, Edward A ^a   Califano, Joseph A ^a   Sidransky, David ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Autosomal dominant 5 gene; Breast cancer; DFNA5; Promoter methylation; The human deafness

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; GENE PRODUCT; MESSENGER RNA; PROTEIN DFNA5; SMALL INTERFERING RNA; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; CELL INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; DFNA5 GENE; DIAGNOSTIC VALUE; DNA METHYLATION; EPIGENETICS; FEMALE; GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LYMPH NODE METASTASIS; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE ANALYSIS; RISK ASSESSMENT;

ADULT; AGED; BREAST NEOPLASMS; CELL LINE, TUMOR; DNA METHYLATION; DOWN-REGULATION; EPISTASIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS; RECEPTORS, ESTROGEN; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 41849089301     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.03.026     Document Type: Article

References (16)

1. Rosenberg K. Ten-year risk of false positive screening mammograms and clinical breast examinations. J. Nurse Midwifery 43 (1998) 394-395
2. Elmore J.G., Barton M.B., Moceri V.M., Polk S., Arena P.J., and Fletcher S.W. Ten-year risk of false positive screening mammograms and clinical breast examinations. N. Engl. J. Med. 338 (1998) 1089-1096
3. Baselga J., and Norton L. Focus on breast cancer. Cancer Cell 1 (2002) 319-322
4. Tognon C., Knezevich S.R., Huntsman D., Roskelley C.D., Melnyk N., Mathers J.A., Becker L., Carneiro F., MacPherson N., Horsman D., Poremba C., and Sorensen P.H. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell 2 (2002) 367-376
5. Herman J.G. Hypermethylation of tumor suppressor genes in cancer. Semin. Cancer Biol. 9 (1999) 359-367
6. Hoque M.O., Feng Q., Toure P., Dem A., Critchlow C.W., Hawes S.E., Wood T., Jeronimo C., Rosenbaum E., Stern J., Yu M., Trink B., Kiviat N.B., and Sidransky D. Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer. J. Clin. Oncol. 24 (2006) 4262-4269
7. van Camp G., Coucke P., Balemans W., van Velzen D., van de Bilt C., van Laer L., Smith R.J., Fukushima K., Padberg G.W., Frants R.R., et al. Localization of a gene for non-syndromic hearing loss (DFNA5) to chromosome 7p15. Hum. Mol. Genet. 4 (1995) 2159-2163
8. Van Laer L., Huizing E.H., Verstreken M., van Zuijlen D., Wauters J.G., Bossuyt P.J., Van de Heyning P., McGuirt W.T., Smith R.J., Willems P.J., Legan P.K., Richardson G.P., and Van Camp G. Nonsyndromic hearing impairment is associated with a mutation in DFNA5. Nat. Genet. 20 (1998) 194-197
9. Thompson D.A., and Weigel R.J. Characterization of a gene that is inversely correlated with estrogen receptor expression (ICERE-1) in breast carcinomas. Eur. J. Biochem. 252 (1998) 169-177
10. Lage H., Helmbach H., Grottke C., Dietel M., and Schadendorf D. DFNA5 (ICERE-1) contributes to acquired etoposide resistance in melanoma cells. FEBS Lett. 494 (2001) 54-59
11. M.S. Kim, X. Chang, K. Yamashita, J.K. Nagpal, J.H Baek, G. Wu, B. Trink, E.A. Ratovitski, M. Mori, D. Sidransky. Aberrant promoter methylation and tumor suppressive activity of the DFNA5 gene in colorectal carcinoma, Oncogene, in press.
12. Kim M.S., Yamashita K., H Baek J., Park H.L., Carvalho A.L., Osada M., Hoque M.O., Upadhyay S., Mori M., Moon C., and Sidransky D. N-Methyl-d-aspartate receptor type 2B is epigenetically inactivated and exhibits tumor-suppressive activity in human esophageal cancer. Cancer Res. 66 (2006) 3409-3418
13. Akino K., Toyota M., Suzuki H., Imai T., Maruyama R., Kusano M., Nishikawa N., Watanabe Y., Sasaki Y., Abe T., Yamamoto E., Tarasawa I., Sonoda T., Mori M., Imai K., Shinomura Y., and Tokino T. Identification of DFNA5 as a target of epigenetic inactivation in gastric cancer. Cancer Sci. 98 (2007) 88-95
14. Fiorelli G., Picariello L., Martineti V., Tonelli F., and Brandi M.L. Functional estrogen receptor beta in colon cancer cells. Biochem. Biophys. Res. Commun. 261 (1999) 521-527
15. Arai N., Strom A., Rafter J.J., and Gustafsson J.A. Estrogen receptor beta mRNA in colon cancer cells: growth effects of estrogen and genistein. Biochem. Biophys. Res. Commun. 270 (2000) 425-431
16. Hoque M.O., Topaloglu O., Begum S., Henrique R., Rosenbaum E., Van Criekinge W., Westra W.H., and Sidransky D. Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects. J. Clin. Oncol. 23 (2005) 6569-6575